2026年1月22日,AVITA医疗内线购买了11 675美元的股票。 An AVITA Medical insider bought $11,675 in shares on Jan. 22, 2026.

2026年1月22日, AVITA Medical(ASX:AVH)的一名内幕人士购买了10 022股,每股1.17澳元,共约11 675澳元。 On January 22, 2026, an insider at AVITA Medical (ASX:AVH) bought 10,022 shares at A$1.17 each, totaling about A$11,675. 该公司设在加利福尼亚州巴伦西亚,利用RECELL系统和RECELL GO开发烧伤、皮肤缺陷和维蒂利奥的再生医学治疗。 The company, based in Valencia, California, develops regenerative medicine treatments for burns, skin defects, and vitiligo using its RECELL System and RECELL GO. AVITA 医疗公司,前称AVITA治疗公司,于2020年注册成立。 AVITA Medical, formerly AVITA Therapeutics, Inc., was incorporated in 2020. 截至报告,其市场上限为2.2655亿美元,P/E负比率为-5.55,债务与股本比率为0.36,流动性比率强劲。 As of the report, it had a market cap of $226.55 million, a negative P/E ratio of -5.55, a debt-to-equity ratio of 0.36, and strong liquidity ratios.